Schedule 13G ownership disclosure

Protara Therapeutics Inc

Common Stock · CUSIP: 74365U107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • JANUS HENDERSON GROUP PLC

    Shares: 2,271,832 · Class: 6.6%

  • Janus Henderson Biotech Innovation Master Fund Ltd

    Shares: 5,448,687 · Class: 6.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000036
Form type
SCHEDULE 13G
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub